AKT1 and neoplasm: Using a Drosophila fly model, a number of selective compounds have been identified that concurrently target PI3K/Akt and Notch, exhibiting anti-inflammatory properties via inhibition of nitric oxide synthase (NOS) and lipoxygenase (LOX), leading to tumour inhibition [202].